secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001193125-25-168096
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics reports preliminary cash balance of $138.5M as of June 30, 2025
--------------------------------------------------------------------------------

- Preliminary unaudited cash, cash equivalents and marketable securities of $138.5M as of June 30, 2025.
- Disclosed in a preliminary prospectus supplement filed under Rule 424(b)(5) on July 29, 2025.
- Financial close for Q2 2025 not complete; amount subject to change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525168096/0001193125-25-168096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525168096/d927864d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-168096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer